Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia.

Coughlin, J M; Ishizuka, K; Kano, S I; Edwards, J A; Seifuddin, F T; Shimano, M A; Daley, E L; Zandi, P P; Leweke, F M; Cascella, N G; Pomper, M G; Yolken, R H; Sawa, A

Coughlin, J M; Ishizuka, K; Kano, S I; Edwards, J A; Seifuddin, F T; Shimano, M A; Daley, E L; Zandi, P P; Leweke, F M; Cascella, N G; Pomper, M G; Yolken, R H; Sawa, A.

Mol Psychiatry ; 18(1): 10-1, 2013 Jan.

Article in En | MEDLINE | ID: mdl-22349781

Subject(s)

Schizophrenia/cerebrospinal fluid; Superoxide Dismutase/cerebrospinal fluid; Adult; Amyloid beta-Peptides/cerebrospinal fluid; Case-Control Studies; Female; Follow-Up Studies; Humans; Linear Models; Male; Peptide Fragments/cerebrospinal fluid; Psychiatric Status Rating Scales; Superoxide Dismutase-1; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Schizophrenia / Superoxide Dismutase Type of study: Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: Mol Psychiatry Journal subject: BIOLOGIA MOLECULAR / PSIQUIATRIA Year: 2013 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google